Yucai Peng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yucai Peng

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Vaccine|December 19, 2025

Herpes zoster mRNA vaccine elicits superior immune responses over licensed vaccines with a favorable safety profile in animal modelsYan Chen, Qi Liu, Chunxia Wang, et al.

Virology Journal|November 12, 2022

An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogsJianglong Li, Qi Liu, Jun Liu, et al.

Frontiers in Immunology|June 21, 2024

Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trialHuan Zhou, Hui Zheng, Yucai Peng, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Vaccine|December 19, 2025

Herpes zoster mRNA vaccine elicits superior immune responses over licensed vaccines with a favorable safety profile in animal modelsYan Chen, Qi Liu, Chunxia Wang, et al.

Virology Journal|November 12, 2022

An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogsJianglong Li, Qi Liu, Jun Liu, et al.

Frontiers in Immunology|June 21, 2024

Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trialHuan Zhou, Hui Zheng, Yucai Peng, et al.

Pageof 2